Findings in Hormones Reported from Purdue University

2011 JUL 28 -- Current study results from the report, "Equol, via dietary sources or intestinal production, may ameliorate estrogen deficiency-induced bone loss," have been published. According to the authors of recent research from West Lafayette, Indiana, "Equol, a product of intestinal metabolism of daidzein, is chemically similar to estrogen (without the lipophilic moiety) and has higher estrogen receptor-beta binding affinity than its parent precursor. In 2004, a long-term, randomized controlled trial that characterized postmenopausal women by their equol-producing status showed stronger advantages to lumbar spine bone mineral density (BMD) in equol-compared with...

Want to see the full article?

• Purchase this article for only $3.00